Chronic Myeloproliferative Disorders (DBCOND0028462)

Identifiers

Synonyms
Chronic Myeloproliferative Disorder / Chronic Myeloproliferative Disease / Chronic myeloproliferative disorder (clinical) / Myeloproliferative neoplasm / Myeloproliferative disorder NOS / Myeloproliferative Disorders / Myeloid proliferation (morphologic abnormality) / Myeloproliferative disorder / Disorder myeloproliferative / Myeloproliferative disorder (disorder) / Chronic neutrophilic leukemia (morphologic abnormality) / Leukemia, Neutrophilic, Chronic / Chronic neutrophilic leukemia (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05260203
MargheRITA (Remote Intelligence for Therapeutic Adherence)No drug interventionssupportive_careNot Availablecompleted
NCT01163201
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignanciestreatment1 / 2withdrawn
NCT00592046
A Phase I Trial of ZIO-101 in Hematologic Cancerstreatment1completed
NCT00935090
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00964821
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT00589602
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other DiseasesNo drug interventionstreatment2terminated
NCT00293384
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplantsupportive_careNot Availablecompleted
NCT00255684
Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancertreatmentNot Availableterminated
NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003687
Treatment for Chronic Pain in Patients With Advanced Cancersupportive_care3completed
NCT00003887
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationNo drug interventionstreatment2completed
NCT00082654
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00899951
Studying Fentanyl in Patients With CancerNot AvailableNot Availableterminated
NCT00005805
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerNo drug interventionssupportive_care3completed
NCT00005797
Bone Marrow Transplant in Treating Patients With Hematologic Cancerstreatment2completed
NCT00946283
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic SyndromeNo drug interventionssupportive_careNot Availableterminated
NCT00245128
Imatinib Mesylate in Treating Patients With Myelofibrosistreatment2terminated
NCT00064311
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantationsupportive_care1 / 2completed
NCT00381693
Azacitidine in Treating Patients With Myelofibrosistreatment2terminated
NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHDsupportive_care2completed
NCT00669578
CC-4047 in Treating Patients With Myelofibrosistreatment1 / 2completed
NCT00003107
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumorstreatment1completed
NCT00750009
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialNo drug interventionsother3completed
NCT00952185
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersNo drug interventionssupportive_careNot Availableterminated
NCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorderstreatment2active_not_recruiting
NCT00691015
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantsupportive_care2completed
NCT00089037
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantationsupportive_care1 / 2completed
NCT00245037
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancertreatment1 / 2completed
NCT00004232
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancersupportive_care1completed
NCT00005852
Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplanttreatment2terminated
NCT00003600
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapysupportive_care3completed
NCT00346359
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancertreatment2completed
NCT00104975
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancertreatment1completed
NCT00002742
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancersupportive_care3completed
NCT00900406
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT00004036
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancersupportive_care1unknown_status
NCT00816413
Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancertreatment1 / 2withdrawn
NCT00003619
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemiatreatment1 / 2completed
NCT00005641
Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantationtreatment2terminated
NCT00134017
Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancertreatment2completed
NCT00066417
Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemiatreatment2terminated
NCT00324324
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplantsupportive_care3terminated
NCT00003816
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancertreatment2 / 3completed
NCT00004058
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disordertreatment1terminated
NCT00438958
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseasestreatment3completed
NCT01164163
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Diseasetreatment1completed
NCT00589563
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancersupportive_care2completed
NCT00004239
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairmenttreatment1terminated
NCT00376922
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesNo drug interventionssupportive_careNot Availablecompleted
NCT01137825
Registry of Older Patients With CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00080925
T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignanciestreatment1completed
NCT00006348
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatmentsupportive_care3completed
NCT00448357
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimentreatment1 / 2completed
NCT00900120
Collecting and Storing Blood Samples From Patients With CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00014482
Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00003082
Monoclonal Antibody Therapy in Treating Patients With Advanced CancerNo drug interventionstreatment1completed
NCT00062231
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancersupportive_careNot Availableterminated
NCT02556931
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignanciestreatment2completed
NCT00433862
Molecular Changes and Biomarkers in Chronic Myeloproliferative DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT00002792
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorderstreatment2completed
NCT00069992
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CMLtreatment2terminated
NCT00806767
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancertreatment2completed
NCT00281801
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT00134004
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancertreatment2completed
NCT00005804
Bone Marrow Transplantation in Treating Patients With Hematologic Cancertreatment2completed
NCT00002504
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancertreatment2completed
NCT00900068
Blood Samples From Patients on a Clinical Trial to CINV During HSCTNo drug interventionsNot AvailableNot Availableterminated
NCT00301912
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancertreatment2withdrawn
NCT00293410
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorderstreatment1completed
NCT00255710
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancersupportive_care1completed
NCT00004181
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasiatreatment2completed
NCT00900055
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or MyelomaNo drug interventionsNot AvailableNot Availablecompleted
NCT00296023
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic CancertreatmentNot Availablecompleted
NCT00068523
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciestreatmentNot Availablecompleted
NCT00003408
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancertreatment2completed
NCT00516503
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancersupportive_care3completed
NCT00036790
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancertreatment1completed
NCT00281879
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancertreatment2terminated
NCT00006379
Non-Ablative Allo HSCT For Hematologic Malignancies or SAAtreatment2completed
NCT00003451
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancertreatment1completed
NCT00782145
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their FamiliesNo drug interventionssupportive_care3completed
NCT00295997
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiatreatmentNot Availableunknown_status
NCT00006083
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Cathetersupportive_care3completed
NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colonsupportive_care1 / 2completed
NCT00290628
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancertreatmentNot Availableterminated
NCT00666211
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainNo drug interventionssupportive_care3completed
NCT00716911
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplantsupportive_careNot Availablecompleted
NCT00132015
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosistreatment2completed
NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantationsupportive_care2terminated
NCT00253552
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisorderstreatmentNot Availableterminated
NCT00042900
Pyroxamide in Treating Patients With Advanced Cancertreatment1completed
NCT00445900
Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasiatreatment2completed
NCT04843475
Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University HospitalNo drug interventionsNot AvailableNot Availableunknown_status
NCT00424242
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastasestreatment0completed
NCT00453206
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT00003406
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancertreatment1 / 2completed
NCT00054236
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemiatreatment1completed
NCT00770419
Perceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00290641
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancertreatmentNot Availablecompleted
NCT00049634
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disordertreatment1 / 2completed
NCT00823524
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancertreatment1 / 2completed
NCT00651716
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantNo drug interventionsNot AvailableNot Availableterminated
NCT00096096
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantationsupportive_care2completed
NCT00004258
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancertreatment1completed
NCT00719563
American Ginseng in Treating Patients With Fatigue Caused by Cancersupportive_care3completed
NCT00437086
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorderstreatment0completed
NCT00005622
Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorderstreatment2completed
NCT00726830
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancersupportive_careNot Availableterminated
NCT00410657
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplantsupportive_care2completed
NCT00114257
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorderstreatment1completed
NCT00053157
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemiasupportive_careNot Availablecompleted
NCT00951626
A Standardized Nursing Intervention Protocol for HCT PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT00513474
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplantsupportive_care1completed
NCT00274820
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disordertreatment2completed
NCT00003331
Combination Chemotherapy in Treating Patients With Advanced Cancertreatment1completed
NCT00993694
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneNot AvailableNot Availablecompleted
NCT00630994
Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosistreatment2terminated
NCT00002980
Decitabine in Treating Patients With Melanoma or Other Advanced Cancertreatment1completed
NCT00053989
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorderstreatment2completed
NCT01077440
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantNo drug interventionsNot AvailableNot Availableterminated
NCT00054340
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disordersupportive_care1 / 2completed
NCT00755040
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorderprevention3completed
NCT00006367
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosistreatment2completed
NCT00005967
Tipifarnib in Treating Patients With Advanced Hematologic Cancertreatment1completed
NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT00448201
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseasetreatment2completed
NCT00004904
Stem Cell Transplantation in Treating Patients With Hematologic Cancertreatment1completed
NCT01101412
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignanciessupportive_care1 / 2withdrawn
NCT00036712
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationNo drug interventionssupportive_care2unknown_status
NCT00281814
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow TransplantNo drug interventionsNot AvailableNot Availablecompleted
NCT00800150
Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatmenttreatment1terminated
NCT00104923
Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancertreatment1completed
NCT00066300
Allogeneic Peripheral Stem Cell Transplantation Followed By Donor Lymphocyte Infusions in Treating Patients With Hematologic Cancertreatment2active_not_recruiting